Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Evidence based medicine: what it is and what it isn't
19969.6k citationsWilliam Rosenberg, R. Brian Haynes et al.BMJprofile →
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
2004906 citationsWilliam Rosenberg et al.profile →
Serum markers detect the presence of liver fibrosis: A cohort study
2004830 citationsWilliam Rosenberg, Michael Becka et al.Gastroenterologyprofile →
Evidence based medicine: an approach to clinical problem-solving
1995797 citationsWilliam Rosenberg et al.BMJprofile →
Countries citing papers authored by William Rosenberg
Since
Specialization
Citations
This map shows the geographic impact of William Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Rosenberg more than expected).
Fields of papers citing papers by William Rosenberg
This network shows the impact of papers produced by William Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Rosenberg. The network helps show where William Rosenberg may publish in the future.
Co-authorship network of co-authors of William Rosenberg
This figure shows the co-authorship network connecting the top 25 collaborators of William Rosenberg.
A scholar is included among the top collaborators of William Rosenberg based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with William Rosenberg. William Rosenberg is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Affronti, Andrea, et al.. (2016). Successful hepatitis C treatment in advanced cirrhosis with DAA reduces HCC incidence. UCL Discovery (University College London).2 indexed citations
Ferenci, Péter, Anna Członkowska, Wolfgang Stremmel, et al.. (2012). EASL Clinical Practice Guidelines: Wilson's disease. UCL Discovery (University College London).18 indexed citations
9.
Tanwar, Sudeep, Douglas Thorburn, Julie Parkes, et al.. (2012). An algorithm combining direct and indirect liver fibrosis tests enhances diagnostic performance for the detection of advanced fibrosis (F3-4) in NAFLD minimising the need for liver biopsy. UCL Discovery (University College London).1 indexed citations
Rosenberg, William, et al.. (2007). Evidence based medicine: What it is and what it isn't (reprinted from BMJ, vol 312, pg 71-72, 1996). UCL Discovery (University College London).42 indexed citations
12.
Patch, Christine, Paul Roderick, & William Rosenberg. (2003). Genetic screening for Hemochromatosis is no less acceptable than biochemical screening.. UCL Discovery (University College London).1 indexed citations
13.
Patch, Craig S, Paul Roderick, & William Rosenberg. (2002). Feasibility and acceptability of two screening strategies for haemochromatosis, report of phase one of a randomised controlled trial.. UCL Discovery (University College London).1 indexed citations
14.
Roderick, Paul, et al.. (2001). Comparison of two screening strategies for haemochromatosis: A pilot study investigating uptake, feasibility and cost. ePrints Soton (University of Southampton).1 indexed citations
15.
Rosenberg, William, et al.. (2000). Automated assays of serum markers of liver fibrosis predict histological hepatic fibrosis.. UCL Discovery (University College London).5 indexed citations
Healey, Christopher, et al.. (1998). Genetic variation in Immune epitopes in core and envelope regions of hepatitis C virus. UCL Discovery (University College London).2 indexed citations
Satsangi, Jack, William Rosenberg, & D. P. Jewell. (1994). THE PREVALENCE OF INFLAMMATORY BOWEL-DISEASE IN RELATIVES OF PATIENTS WITH CROHNS-DISEASE. UCL Discovery (University College London).74 indexed citations
20.
Moss, Paul, et al.. (1991). EXTENSIVE CONSERVATION OF ALPHA-CHAIN AND BETA-CHAIN OF THE HUMAN T-CELL ANTIGEN RECEPTOR RECOGNIZING HLA-A2 AND INFLUENZA-A MATRIX PEPTIDE. UCL Discovery (University College London).2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.